support 
Fierce Pharma
APRIL 10, 2024
The FDA appears receptive to the idea of using the measurement to support accelerated approvals of new drugs, even though the agency has a few questions. . | New data have come forward pointing to a link between achieving undetectable minimal residual disease (MRD) and improved treatment outcomes in multiple myeloma.
Fierce Pharma
FEBRUARY 27, 2024
Delivering on these heightened expectations has fueled the urgency to invest in patient engagement and support. A seismic shift has occurred in the healthcare landscape.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
APRIL 18, 2023
Embracing Personalization in Biopharma Patient Support Programs mteefey Tue, 04/18/2023 - 14:48
MedCity News
APRIL 16, 2024
CTO Aneesh Chopra will moderate a webinar on April 16 at 1pm ET on eConsent, The post EConsent Workflows Must Evolve to Support Interoperability and Health Equity appeared first on MedCity News. Former U.S.
Advertisement
Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support studies throughout (..)
Fierce Pharma
MARCH 19, 2024
Now, the company looks to support the upcoming launch by selling shares. Just a few days ago, Madrigal Pharmaceuticals made history by winning FDA approval for its metabolic dysfunction-associated steatohepatitis (MASH) med Rezdiffra.
Fierce Pharma
AUGUST 3, 2023
In this episode of "The Top Line," Zoey Becker talks with Dr. | This week on "The Top Line," we discuss how to support patients during the cancer drug shortage, plus this week's headlines.
Advertisement
As demand for advanced therapies increases, so does the need for more specialized supply chain support, as these products have strict transportation and handling requirements. It is crucial to ensure supply chain risks are mitigated and have proactive strategies in place to address unforeseen challenges before they become an issue.
Advertisement
We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows. In this paper, we explore real-time data access and analysis for proactive study management.
Advertiser: ZoomInfo
Leveraging a data provider to help identify and connect with qualified prospects supports company revenue goals by alleviating common headaches associated with prospecting research and empowers sales productivity. So what’s the problem? Many organizations fail to properly evaluate vendors during the selection process.
Advertisement
Revvity Signals provides a centralized analytics platform built to support today’s clinical study requirements and increase trial efficiency, glean actionable analytic insights, automate data collection and harmonization, support safety and efficacy decision-making, and enable a singular view across a company’s entire candidate portfolio.
Advertiser: ZoomInfo
The growing demand among buyers for open marketing platforms that can support “BYOD” (bring your own data). How AI-powered analytics are leading to more intriguing and satisfying customer interactions.
Expert insights. Personalized for you.
310 
Let's personalize your content